- Home
- EXEL vs X Comparison
EXEL vs X Comparison
Compare EXEL & X Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- X
- Stock Information
- Founded
- EXEL 1994
- X 1901
- Country
- EXEL United States
- X United States
- Employees
- EXEL N/A
- X N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- X Steel/Iron Ore
- Sector
- EXEL Health Care
- X Industrials
- Exchange
- EXEL Nasdaq
- X Nasdaq
- Market Cap
- EXEL 9.8B
- X 9.2B
- IPO Year
- EXEL 2000
- X N/A
- Fundamental
- Price
- EXEL $36.17
- X $42.45
- Analyst Decision
- EXEL Buy
- X Buy
- Analyst Count
- EXEL 18
- X 5
- Target Price
- EXEL $37.59
- X $39.91
- AVG Volume (30 Days)
- EXEL 2.2M
- X 4.8M
- Earning Date
- EXEL 05-13-2025
- X 05-01-2025
- Dividend Yield
- EXEL N/A
- X 0.47%
- EPS Growth
- EXEL 170.77
- X N/A
- EPS
- EXEL 1.76
- X 0.43
- Revenue
- EXEL $2,168,701,000.00
- X $15,207,000,000.00
- Revenue This Year
- EXEL $5.78
- X $9.41
- Revenue Next Year
- EXEL $10.94
- X $3.15
- P/E Ratio
- EXEL $20.64
- X $98.44
- Revenue Growth
- EXEL 18.50
- X N/A
- 52 Week Low
- EXEL $20.14
- X $26.92
- 52 Week High
- EXEL $40.26
- X $46.18
- Technical
- Relative Strength Index (RSI)
- EXEL 43.89
- X 52.06
- Support Level
- EXEL $34.90
- X $40.41
- Resistance Level
- EXEL $40.26
- X $44.71
- Average True Range (ATR)
- EXEL 1.21
- X 1.31
- MACD
- EXEL -0.19
- X -0.19
- Stochastic Oscillator
- EXEL 23.69
- X 57.52
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About X United States Steel Corporation
United States Steel Corp operates primarily in the United States but also has a steelmaking capacity in Slovakia. The company's operating segments include North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment includes U. S. Steel's integrated steel plants and equity investees in North America involved in the production of slabs, strip mill plates, sheets, and tin mill products, as well as all iron ore and coke production facilities in the United States. It primarily serves North American customers in the service center, conversion, transportation, construction, container, and appliance, and electrical markets.